ezCater
ezCater connects workplaces with restaurants and helps organisations manage catering, meal programs and food spending.
$100MSeries D-2
ParticipantI
Invus
Activity from announced rounds
Activity in this selectionUnited States · Dec 31, 2021 · Dec 1, 2021
Invus is the investment-firm name used by Encoded Therapeutics and in LifeMine transaction-counsel coverage.
Recorded funding activity
Encoded develops precision gene therapies for neurological disorders. LifeMine uses fungal genomes for drug discovery, while City develops RNA-interference medicines. The records identify different therapeutic approaches without substituting an unnamed parent or fund.
- Rounds participated in
- 1
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $100M 1 disclosed · full round size, not this investor’s share